| |
| |
|
| Insider
Information: |
Chien Jennifer |
| Relationship: |
EVP, Head of North Ame... |
| City: |
Pittsburgh |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
6,852 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$268,187 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
6,852 |
|
|
| Total
Value |
$268,187 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rhythm Pharmaceuticals, Inc. |
RYTM |
EVP, Head of North Ame... |
2024-03-20 |
6,852 |
2022-02-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-03-20 |
4 |
AS |
$38.22 |
$707,005 |
D/D |
(18,235) |
6,852 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-03-19 |
4 |
AS |
$39.22 |
$608,498 |
D/D |
(15,515) |
25,087 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
40,602 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-13 |
4 |
AS |
$49.83 |
$30,645 |
D/D |
(615) |
6,852 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-12 |
4 |
AS |
$51.38 |
$52,562 |
D/D |
(1,023) |
7,467 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
8,490 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,438 |
6,459 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,513 |
4,513 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2024-02-01 |
4 |
AS |
$45.06 |
$67,230 |
D/D |
(1,492) |
3,021 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-14 |
4 |
AS |
$32.01 |
$437,819 |
D/D |
(13,677) |
0 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-14 |
4 |
OE |
$6.80 |
$81,804 |
D/D |
12,030 |
13,677 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-09 |
4 |
AS |
$27.37 |
$95,183 |
D/D |
(3,438) |
1,647 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-09 |
4 |
OE |
$6.80 |
$23,378 |
D/D |
3,438 |
5,085 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-08 |
4 |
AS |
$28.64 |
$165,104 |
D/D |
(5,712) |
1,647 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-08 |
4 |
OE |
$6.80 |
$38,842 |
D/D |
5,712 |
7,359 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-03 |
4 |
AS |
$28.00 |
$2,240 |
D/D |
(80) |
1,647 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-11-03 |
4 |
OE |
$6.80 |
$544 |
D/D |
80 |
1,727 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-09-05 |
4 |
AS |
$28.05 |
$172,958 |
D/D |
(6,166) |
1,647 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-09-05 |
4 |
OE |
$6.80 |
$30,729 |
D/D |
4,519 |
7,813 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-08-09 |
4 |
AS |
$24.66 |
$42,366 |
D/D |
(1,718) |
3,294 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-08-09 |
4 |
OE |
$6.80 |
$11,682 |
D/D |
1,718 |
5,012 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-08-07 |
4 |
OE |
$6.80 |
$58,419 |
D/D |
8,591 |
14,517 |
0 |
- |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-08-07 |
4 |
AS |
$24.18 |
$271,347 |
D/D |
(11,223) |
3,294 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-02-14 |
4 |
AS |
$26.87 |
$17,062 |
D/D |
(635) |
4,940 |
0 |
% |
|
| RYTM |
Rhythm Pharmaceuticals, I... |
EVP, Head of North America |
• – – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,031 |
5,575 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
